Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dacomitinib in HER2-positive advanced gastric cancer
NCT01152853Phase 2Completed
- Sponsor
- Seoul National University Hospital
- Start
- Jul 2010
- Primary completion
- Jul 2011
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dacomitinib in gastric cancer (GC), sponsored by Seoul National University Hospital. Started Jul 2010; status: completed.
02
Drugs
dacomitinib
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT01152853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01152853.